Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism HIPK2 inhibitors(homeodomain interacting protein kinase 2 inhibitors), SMAD3 inhibitors(Mothers against decapentaplegic homolog 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Other Diseases | Discovery | - | 18 Aug 2022 | |
| Other Diseases | Discovery | - | 18 Aug 2022 | |
| Pulmonary Fibrosis | Discovery | - | 18 Aug 2022 | |
| Pulmonary Fibrosis | Discovery | - | 18 Aug 2022 | |
| Renal fibrosis | Discovery | - | 18 Aug 2022 | |
| Renal fibrosis | Discovery | - | 18 Aug 2022 |





